<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04683133</url>
  </required_header>
  <id_info>
    <org_study_id>The FAST OCT study</org_study_id>
    <nct_id>NCT04683133</nct_id>
  </id_info>
  <brief_title>The FAST OCT Study</brief_title>
  <official_title>Association Between 3D Quantitative Angiography Based FFR and Luminal Obstruction as Detected by Optical Coherence Tomography (OCT): the FAST OCT Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasmus Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pie Medical Imaging</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Erasmus Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial is designed to associate angiography-based fractional flow reserve (3D-angio-based&#xD;
      FFR) values with optical coherence tomography findings in pre- and post-percutaneous coronary&#xD;
      intervention in patients with non-ST segment elevation acute coronary syndromes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, multicenter, international, no-randomized, single-arm, investigator-initiated&#xD;
      study, enrolling up to 200 patients with intermediate to severe coronary stenosis (30-90%&#xD;
      diameter stenosis) in patients presenting with NST-ACS requiring coronary angiography&#xD;
      assessment.&#xD;
&#xD;
      Patients will receive ad-hoc OCT evaluation of the target vessels and offline 3D-angio-based&#xD;
      FFR evaluation.&#xD;
&#xD;
      The primary study parameter is the association between 3D-angio-based FFR values and OCT&#xD;
      detected minimum luminal area pre- and post-PCI&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective, multicenter, international, no-randomized, single-arm, investigator-initiated study</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The association between 3D-angio-based FFR and OCT detected minimum luminal area pre- and post-PCI</measure>
    <time_frame>0 days</time_frame>
    <description>The association between 3D-angio-based FFR and OCT detected minimum luminal area pre- and post-PCI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The association between 3D-angio-based FFR values and OCT detected causes of luminal obstruction pre-PCI</measure>
    <time_frame>0 days</time_frame>
    <description>The association between 3D-angio-based FFR values and OCT detected causes of luminal obstruction pre-PCI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The association between 3D-angio-based FFR values and OCT detected causes of luminal obstruction post-PCI</measure>
    <time_frame>0 days</time_frame>
    <description>The association between 3D-angio-based FFR values and OCT detected causes of luminal obstruction post-PCI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accuracy of 3D-angio-based FFR to detect intraluminal obstructions pre-PCI</measure>
    <time_frame>0 days</time_frame>
    <description>Accuracy of 3D-angio-based FFR to detect intraluminal obstructions pre-PCI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accuracy of 3D-angio-based FFR to detect intraluminal obstructions post-PCI</measure>
    <time_frame>0 days</time_frame>
    <description>Accuracy of 3D-angio-based FFR to detect intraluminal obstructions post-PCI</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Tomography, Optical Coherence</condition>
  <condition>Myocardial Revascularization</condition>
  <condition>NSTEMI - Non-ST Segment Elevation MI</condition>
  <condition>Unstable Angina</condition>
  <condition>Coronary Arteriosclerosis</condition>
  <condition>3D-angio-based FFR</condition>
  <arm_group>
    <arm_group_label>Single arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Optical coherence tomography evaluation of coronary arteries with intermediate to severe stenosis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Optical coherence tomography assessment</intervention_name>
    <description>Optical coherence tomography assessment of coronary arteries with intermediate to severe stenosis</description>
    <arm_group_label>Single arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years or older&#xD;
&#xD;
          -  Presenting with NST-ACS&#xD;
&#xD;
          -  At least one coronary vessel with intermediate to severe coronary stenosis (30% to 90%&#xD;
             by visual estimation or online QCA)&#xD;
&#xD;
          -  Target vessel with a reference vessel diameter (RVD) ≥2.5 and ≤ 5.0 mm as assessed by&#xD;
             QCA or visual estimation&#xD;
&#xD;
          -  The patient is willing to participate in the study&#xD;
&#xD;
          -  Target vessel suitable for OCT imaging&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Target vessel with a distal Thrombolysis In Myocardial Infarction (TIMI) flow &lt;3&#xD;
&#xD;
          -  Target lesion located within 5.0 mm of vessel origin&#xD;
&#xD;
          -  Severe tortuosity&#xD;
&#xD;
          -  Chronic total occlusion of the target vessel&#xD;
&#xD;
          -  Target lesion is located in or supplied by an arterial or venous bypass graft.&#xD;
&#xD;
          -  Impaired renal function (eGFR &lt;30ml/min) *&#xD;
&#xD;
          -  Pregnant or breastfeeding patients *&#xD;
&#xD;
          -  Patient has a known allergy to contrast medium *&#xD;
&#xD;
          -  Contraindication for the use of nitrates *&#xD;
&#xD;
          -  Life expectancy &lt;12 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joost Daemen, MD;PhD</last_name>
      <phone>+31 10 703 5260</phone>
      <email>j.daemen@erasmusmc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Maria Natalia Tovar Forero, MD</last_name>
      <phone>+31 10 703 8896</phone>
      <email>m.tovarforero@erasmusmc.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Joost Daemen, MD;PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Natalia Tovar Forero, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 21, 2020</study_first_submitted>
  <study_first_submitted_qc>December 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 24, 2020</study_first_posted>
  <last_update_submitted>December 21, 2020</last_update_submitted>
  <last_update_submitted_qc>December 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erasmus Medical Center</investigator_affiliation>
    <investigator_full_name>Joost Daemen</investigator_full_name>
    <investigator_title>Interventional Cardiologist</investigator_title>
  </responsible_party>
  <keyword>OCT</keyword>
  <keyword>3D-angio-based FFR</keyword>
  <keyword>Coronary Arteriosclerosis</keyword>
  <keyword>NST-ACS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arteriosclerosis</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

